drugset / Trial / NCT01887288
Capecitabine With Digoxin for Metastatic Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the Growth Modulation Index (GMI) of the combination of metronomic capecitabine with oral digoxin in metastatic breast cancer
Timeline
- Start
- 2013-04
- Primary completion
- 2015-11
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 650 mg/m2 | Oral |
| Subject | Digoxin | Other / unclassified | 0.25 mg | Oral |